Zhaoke Ophthalmology tumbles 8% in Hong Kong tradingMarket Movers·Nov 16, 2026 at 01:50 AM06622-1.74%
Zhaoke Ophthalmology Wins NMPA Approval for Cyclosporine Eye GelPUBT·Nov 13, 2026 at 10:42 AM06622-1.74%
Zhaoke Ophthalmology Files HKEX Next-Day Disclosure on Share Buyback for CancellationPUBT·Nov 9, 2026 at 02:25 AM06622-1.74%
Zhaoke Ophthalmology climbs 6% on Australian TGA GMP certificationMarket Movers·Oct 27, 2026 at 07:36 AM06622-1.74%
ZHAOKE OPHTH-B hits a new 52-week low, currently trading at $1.88, down approximately 1%Market Movers·Oct 26, 2026 at 01:34 AM06622-1.74%
Zhaoke Ophthalmology Discloses Share Buyback for Cancellation in HKEX FilingPUBT·Oct 21, 2026 at 08:49 AM06622-1.74%
Hong Kong Small-Caps Report Card: CNTC Int'l Revenue Up 8.3%, Tech-Ophthalmic Drug Nears ApprovalGlobal Report·Oct 20, 2026 at 10:15 AM06182-9.87%01879+8.96%
Weekly Recap | ZHAOKE OPHTH-B flat, thin volume narrow rangeWeekly Review·Sep 19, 2026 at 05:15 AM06622-1.74%
Forget the Rust, It’s All About AI Agents and Gen-Z Buyouts NowGlobal Report·Sep 18, 2026 at 10:14 AM06622-1.74%01910-1.12%
Weekly Recap | ZHAOKE OPHTH-B -1.97%, a quiet narrow-range weekWeekly Review·Sep 12, 2026 at 07:24 AM06622-1.74%
Zhaoke Ophthalmology says presbyopia eye drop YUVEZZI meets primary endpoint in China Phase II trialPUBT·Sep 4, 2026 at 10:39 AM06622-1.74%
China Qidian Guofeng FY26 H1 loss widens to RMB 36.77 million; revenue rises 29.4% to RMB 235.47 millionPUBT·Aug 28, 2026 at 09:52 AM01280-0.64%
Zhaoke Ophthalmology signs exclusive distribution deal with Pharmentum Biopharma for epinastine eye drops in ChinaPUBT·Aug 12, 2026 at 08:55 AM06622-1.74%